There are a number of genetic disorders that are seen more commonly in the Ashkenazi population, several with links to cancer risk.

Iobenguane I-131 (Azedra®) is a radiopharmaceutical medication used in the treatment of iobenguane scan positive pheochromocytoma and paraganglioma in individuals 12 years or older .

Mogamulizumab-kpkc is a CC chemokine receptor type 4 directed monoclonal antibody used in the treatment of Sezary syndrome and mycosis fungoides.

Ivosidenib (Tibsovo®) is an oral medication used in the treatment of isocitrate dehydrogenase-1 (IDH-1) positive relapsed or refractory acute myeloid leukemia.